NOVEL COMPOUND ISOLATED FROM ACANTHOPANAX SP. FRUIT EXTRACT, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING HYPERTENSION, CONTAINING SAME

WIPO Patent Application WO/2019/240508

A1

The present invention relates to a composition containing a novel compound isolated from an Acanthopanax sp. fruit extract. More specifically, a novel compound of the present invention can effectively inhibit blood pressure elevation, caused by the action of an angiotensin converting enzyme (ACE), by inhibiting the ACE, thereby being effectively usable as a pharmaceutical composition and a health functional food for preventing and treating hypertension.

LEE DAE YOUNG (KR)
KIM GEUM SOOG (KR)
LEE YOUNG SEOB (KR)
LEE JAE WON (KR)
CHOI DOO JIN (KR)
LEE SEUNG EUN (KR)
KIM HYUNG DON (KR)
SEO KYUNG HYE (KR)
BAEK NAM IN (KR)
JUNG IN HO (KR)
KIM HA NEUL (KR)

PCT/KR2019/007128

December 19, 2019

June 13, 2019

Click for automatic bibliography generation  

REPUBLIC KOREA MAN RURAL DEV ADMIN (KR)
DAE HWA PHARMA CO LTD (KR)

C07J17/00; A23L33/105; A61P9/12

KR20170014566A	2017-02-08
KR20140144592A	2014-12-19
KR20120085048A	2012-07-31

YOSHIZUML K. ET AL.: "Lupane-Type Saponins from Leaves of Acanthopanax sessiliflorus and Their Inhibitory Activity on Pancreatic Lipase", J. AGRIC. FOOD CHERN., vol. 54, 2006, pages 335 - 341, XP018020230
PARK, S. -Y. ET AL.: "New 3,4-seco-Lupane-Type Triterpene Glycosides from Acanthopanax senticosus forma inermis", J. NAT , PROD., vol. 63, 2000, pages 1630 - 1633, XP018005727

ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM (KR)

View/Download PDF      PDF Help

Previous Patent: BIOMARKER FOR PREDICTING EFFECTIVENESS FOR AUTOIMMUNE DISEASE TREATMENT, DIAGNOSTIC KIT, AND USE FOR...

Next Patent: CONTAINER STOPPER AND CONTAINER INCLUDING SAME